International Biotechnology (LON:IBT – Get Free Report)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 953.56 and traded as high as GBX 1,090. International Biotechnology shares last traded at GBX 1,083.50, with a volume of 59,399 shares changing hands.
International Biotechnology Stock Performance
The company has a quick ratio of 0.32, a current ratio of 0.11 and a debt-to-equity ratio of 9.43. The company has a market capitalization of £342.15 million, a PE ratio of 4.45 and a beta of 0.52. The company has a 50-day moving average price of GBX 986.45 and a two-hundred day moving average price of GBX 954.34.
International Biotechnology (LON:IBT – Get Free Report) last released its quarterly earnings data on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. The firm had revenue of GBX 24 million during the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%. Analysts predict that International Biotechnology will post 0.9435943 EPS for the current fiscal year.
International Biotechnology Company Profile
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.
Further Reading
- Five stocks we like better than International Biotechnology
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
